Close
Back to CNAT Stock Lookup

Conatus Pharmaceuticals (CNAT) – Hot FDA News

Jun 24, 2019 04:07 PM Conatus Pharmaceuticals (CNAT) ENCORE-LF and ENCORE-PH Phase 2b Clinical Trials in NASH Didn't Meet Primary Endpoint
Mar 21, 2019 04:14 PM Conatus (CNAT) falls 45% after announcing emricasan did not have the desired effect in earlier-stage NASH fibrosis patients
Dec 6, 2018 06:20 AM
Apr 4, 2018 04:07 PM
Oct 18, 2017 04:26 PM
Jan 5, 2016 04:07 PM

Back to CNAT Stock Lookup